Octopus Biosafety SA (MLOCT) Ratios
Octopus Biosafety SA Ratios
FR:MLOCT's free cash flow for Q? was ―. For the fiscal year, FR:MLOCT's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.
| Ratios | Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.31 | 1.26 | 0.40 | 0.54 | 1.35 |
| Quick Ratio | 0.30 | 1.17 | 0.14 | 0.25 | 1.10 |
| Cash Ratio | 0.02 | 0.29 | 0.02 | 0.04 | 0.63 |
| Solvency Ratio | 0.02 | -1.99 | -0.18 | -0.22 | -0.19 |
| Operating Cash Flow Ratio | 0.00 | 0.00 | 0.18 | 0.55 | 0.87 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 2.11 | 1.03 | 249.66 |
| Net Current Asset Value | $ -835.46K | $ -220.68K | $ -1.97M | $ -1.37M | $ -369.82K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.12 | 0.46 | 0.33 | 1.02 | 0.21 |
| Debt-to-Equity Ratio | -0.83 | 112.57 | -0.37 | -2.71 | 1.24 |
| Debt-to-Capital Ratio | -5.01 | 0.99 | -0.60 | 1.58 | 0.55 |
| Long-Term Debt-to-Capital Ratio | -0.32 | 0.99 | -0.27 | 5.96 | 0.55 |
| Financial Leverage Ratio | -0.75 | 245.59 | -1.13 | -2.67 | 5.93 |
| Debt Service Coverage Ratio | 0.14 | -64.21 | -1.40 | -0.52 | -27.18 |
| Interest Coverage Ratio | -684.78 | -415.89 | -159.36 | -128.60 | -157.33 |
| Debt to Market Cap | 0.20 | 0.11 | 0.32 | 0.54 | 0.08 |
| Interest Debt Per Share | 0.04 | 0.02 | 0.13 | 0.43 | 0.12 |
| Net Debt to EBITDA | -3.39 | -0.19 | -0.99 | -2.18 | 0.39 |
| Profitability Margins | |||||
| Gross Profit Margin | -642.91% | -30.50% | -252.89% | -1650.30% | -613.65% |
| EBIT Margin | -1601.06% | -627.05% | -3329.84% | -1868.04% | -471.64% |
| EBITDA Margin | -295.83% | -520.01% | -2227.96% | -1128.30% | -258.02% |
| Operating Profit Margin | -1601.06% | -627.05% | -3372.65% | -1699.15% | -627.37% |
| Pretax Profit Margin | -1603.40% | -628.56% | -4401.33% | -1881.25% | -475.63% |
| Net Profit Margin | -1260.05% | -774.83% | -3682.07% | -1512.45% | -372.51% |
| Continuous Operations Profit Margin | -1203.72% | -711.90% | -3682.07% | -1512.45% | -372.51% |
| Net Income Per EBT | 78.59% | 123.27% | 83.66% | 80.40% | 78.32% |
| EBT Per EBIT | 100.15% | 100.24% | 130.50% | 110.72% | 75.81% |
| Return on Assets (ROA) | -134.66% | -230.51% | -49.17% | -59.53% | -37.41% |
| Return on Equity (ROE) | 100.48% | -56612.49% | 55.80% | 158.93% | -222.02% |
| Return on Capital Employed (ROCE) | 168.94% | -424.96% | 65.22% | 1283.80% | -124.39% |
| Return on Invested Capital (ROIC) | 576.13% | -403.39% | 68.58% | -104.77% | -97.09% |
| Return on Tangible Assets | -164.18% | -260.22% | -67.64% | -89.11% | -47.79% |
| Earnings Yield | -23.78% | -57.24% | -47.36% | -31.68% | -14.24% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.20 | 0.65 | 0.07 | 0.18 | 0.51 |
| Payables Turnover | 0.99 | 0.88 | 0.39 | 3.94 | 4.84 |
| Inventory Turnover | 28.05 | 7.48 | 0.11 | 2.26 | 5.88 |
| Fixed Asset Turnover | 0.64 | 1.82 | 0.27 | 0.44 | 0.91 |
| Asset Turnover | 0.11 | 0.30 | 0.01 | 0.04 | 0.10 |
| Working Capital Turnover Ratio | -0.19 | -0.30 | -0.02 | -0.30 | 4.28 |
| Cash Conversion Cycle | 1505.41 | 198.97 | 7340.57 | 2048.66 | 707.31 |
| Days of Sales Outstanding | 1860.71 | 563.73 | 4934.29 | 1979.64 | 720.65 |
| Days of Inventory Outstanding | 13.01 | 48.78 | 3340.02 | 161.68 | 62.07 |
| Days of Payables Outstanding | 368.31 | 413.54 | 933.74 | 92.66 | 75.41 |
| Operating Cycle | 1873.72 | 612.51 | 8274.31 | 2141.32 | 782.72 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | 0.00 | 0.12 | 0.24 | 0.24 |
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.12 | 0.24 | 0.24 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.91 | 0.57 | 2.05 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 22.34 | 14.79 | 4.27 |
| Free Cash Flow Yield | 0.00% | 0.00% | 28.74% | 30.99% | 16.33% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -4.20 | -1.75 | -2.11 | -3.16 | -7.02 |
| Price-to-Sales (P/S) Ratio | 52.98 | 13.54 | 77.75 | 47.74 | 26.16 |
| Price-to-Book (P/B) Ratio | -4.22 | 989.05 | -1.18 | -5.02 | 15.59 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 0.00 | 0.00 | 3.48 | 3.23 | 6.12 |
| Price-to-Operating Cash Flow Ratio | 0.00 | 0.00 | 3.48 | 3.23 | 6.12 |
| Price-to-Earnings Growth (PEG) Ratio | 0.07 | 0.04 | 0.11 | -0.13 | 0.11 |
| Enterprise Value Multiple | -21.29 | -2.79 | -4.48 | -6.41 | -9.75 |
| Enterprise Value | 3.30M | 3.33M | 2.18M | 4.83M | 5.62M |
| EV to EBITDA | -21.29 | -2.79 | -4.48 | -6.41 | -9.75 |
| EV to Sales | 63.00 | 14.53 | 99.83 | 72.36 | 25.16 |
| EV to Free Cash Flow | 0.00 | 0.00 | 4.47 | 4.89 | 5.89 |
| EV to Operating Cash Flow | 0.00 | 0.00 | 4.47 | 4.89 | 5.89 |
| Tangible Book Value Per Share | -0.05 | -0.01 | -0.46 | -0.30 | -0.03 |
| Shareholders’ Equity Per Share | -0.04 | 0.00 | -0.35 | -0.16 | 0.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | -0.13 | 0.16 | 0.20 | 0.22 |
| Revenue Per Share | 0.00 | 0.02 | 0.01 | 0.02 | 0.06 |
| Net Income Per Share | -0.04 | -0.12 | -0.20 | -0.25 | -0.21 |
| Tax Burden | 0.79 | 1.23 | 0.84 | 0.80 | 0.78 |
| Interest Burden | 1.00 | 1.00 | 1.32 | 1.01 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.00 | 0.00 | -607.33 | -978.75 | -1148.25 |
Currency in EUR
